Exposed mucosal and tissue proteins at sites of damage

Exposed mucosal and tissue proteins at sites of damage represent a heterogeneous group of proteins, including albumin, fibrinogen, and globulins, that become accessible following the disruption of the epithelial barrier. In the context of gastrointestinal pathology, these proteins are found at the base of ulcers or erosions where the protective mucus-bicarbonate layer has been breached (StatPearls, NBK551527). These proteins serve as a therapeutic target for mucosal protectant drugs, such as sucralfate, which undergo polyanionic polymerization in acidic environments to bind selectively to the positively charged proteins at the injury site (PubChem, CID 6398). This interaction creates a physical, paste-like barrier that shields the damaged tissue from aggressive factors like gastric acid, pepsin, and bile salts, thereby promoting natural healing processes. Beyond the GI tract, targeting exposed tissue proteins is a strategy used in wound care and the treatment of radiation-induced mucositis to provide localized cytoprotection. This target is unique because it is defined by the pathological state of the tissue rather than a specific genetic or molecular identity. Therapeutic interventions targeting these proteins are generally non-systemic, acting locally at the site of injury to minimize systemic side effects. The efficacy of drugs hitting this target is often dependent on the local pH and the presence of active inflammation or necrosis (StatPearls, NBK537071).

Other names

Ulcerated tissue proteinsExposed mucosal proteinsNecrotic tissue proteinsExposed basement membrane proteinsUlcer base proteins

Formation of a physical protective barrier through ionic binding to exposed proteins, preventing further chemical or enzymatic damage to the underlying tissue.